Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
• About Us
• Media Contact
• Frequently Asked Questions
• Media Site Map

CDC News
• Press Release Library
• Transcripts
• MMWR Summaries
• B-Roll Footage
• Upcoming Events

Related Links
• Centers at CDC
• Data and Statistics
• Health Topics A-Z
• Image Library
• Publications, Software and Other Products
• Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394

 


MMWR
Synopsis for September 16, 2005

The MMWR is embargoed until Thursday, 12 PM EDT.

  1. Direct and Indirect Effects of Routine Immunization with 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease – United States, 1998-2003
  2. Improper Disposal of Hazardous Substances and Resulting Injuries – Selected States, January 2001 – March 2005
  3. Update: Influenza Activity – United States and Worldwide, May 22-September 3, 2005, and 2005-06 Season Vaccination Recommendations
There is no MMWR telebriefing scheduled for September 15, 2005

Direct and Indirect Effects of Routine Immunization with
7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease – United States, 1998-2003

Routine immunization of U.S. children with the pneumococcal conjugate vaccine prevented over 29,000 cases of severe bacterial disease in 2003.

PRESS CONTACT:
Deron C. Burton, MD, MPH

EIS Officer
Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases
(404) 639-3286
 

Routine immunization of U.S. children with the 7-valent pneumococcal conjugate vaccine (PCV7) since 2000 has substantially reduced the number of cases of severe disease caused by the bacteria Streptococcus pneumoniae. Because the vaccine prevents spread of the bacteria between individuals, we found that serious disease was less common even in people who were not targeted for vaccination. This ‘herd immunity effect’ was twice as large as the direct protective effect of the vaccine on immunized children in 2003 and is what makes a vaccine like this so important for public health.

Improper Disposal of Hazardous Substances and Resulting Injuries – Selected States,
January 2001 – March 2005

Routine immunization of U.S. children with the 7-valent pneumococcal conjugate vaccine (PCV7) since 2000 has substantially reduced the number of cases of severe disease caused by the bacteria Streptococcus pneumoniae. Because the vaccine prevents spread of the bacteria between individuals, we found that serious disease was less common even in people who were not targeted for vaccination. This ‘herd immunity effect’ was twice as large as the direct protective effect of the vaccine on immunized children in 2003 and is what makes a vaccine like this so important for public health.

PRESS CONTACT:
ATSDR/NCEH Office of Communications

(404) 498-0700
 

This report describes examples and summarizes the 107 events involving improper disposal of hazardous substances reported to the Agency for Toxic Substances and Disease Registry (ATSDR) by 18 states in the Hazardous Substances Emergency Events Surveillance (HSEES) system during January 2001–March 2005. Many consumer and industrial products, including fuels, solvents, fertilizers, pesticides, paints, and household cleaning disinfectants, contain hazardous substances. Improper disposal of these materials can lead to unexpected releases of toxins that are hazardous to humans and harmful to the environment.

Update: Influenza Activity – United States and Worldwide, May 22-September 3, 2005, and 2005-06 Season Vaccination Recommendations

Vaccination is the best way to prevent influenza.

PRESS CONTACT:
Mark Katz, MD

Influenza Branch, DVRD, CDC Division of Media Relations
(404) 639-3286
 

From May 22—September 3, influenza A and influenza B viruses circulated worldwide and were identified sporadically in North America. The circulating strains of the virus looked very similar to the strains that were used to make the vaccine for the upcoming influenza season. This is encouraging that the match between vaccine and circulating influenza strains will be a good one. However, it is impossible to predict which influenza strain will be most common in the upcoming season. Vaccination is the best way to prevent influenza. People in high risk groups should receive the trivalent inactivated influenza vaccine until October 24, 2005; after that date the vaccine should be made available to everyone. Persons displaced by Hurricane Katrina living in crowded group settings should receive influenza vaccine.


Media Home | Accessibility | Privacy Policy | Contact Us
CDC Home | Search | Health Topics A-Z

This page last reviewed September 16, 2005
URL: http://www.cdc.gov/media/mmwrnews/n050916.htm

Centers for Disease Control and Prevention
Office of Communication